Related Experiment Video
Updated: Oct 3, 2025
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
LPS-induced lipid alterations in microglia revealed by MALDI mass spectrometry-based cell fingerprinting in
Martina Blank1,2, Thomas Enzlein3, Carsten Hopf4,5
1Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Paul-Wittsack Str. 10, 68163, Mannheim, Germany. martina.blank@ufsc.br.
Abstract:
Pathological microglia activation can promote neuroinflammation in many neurodegenerative diseases, and it has therefore emerged as a potential therapeutic target. Increasing evidence suggests alterations in lipid metabolism as modulators and indicators in microglia activation and its effector functions. Yet, how lipid dynamics in activated microglia is affected by inflammatory stimuli demands additional investigation to allow development of more effective therapies. Here, we report an extensive matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS) whole cell fingerprinting workflow to investigate inflammation-associated lipid patterns in SIM-A9 microglial cells. By combining a platform of three synergistic MALDI MS technologies we could detect substantial differences in lipid profiles of lipopolysaccharide (LPS)- stimulated and unstimulated microglia-like cells leading to the identification of 21 potential inflammation-associated lipid markers. LPS-induced lipids in SIM-A9 microglial cells include phosphatidylcholines, lysophosphatidylcholines (LysoPC), sphingolipids, diacylglycerols and triacylglycerols. Moreover, MALDI MS-based cell lipid fingerprinting of LPS-stimulated SIM-A9 microglial cells pre-treated with the non-selective histone deacetylase inhibitor suberoylanilide hydroxamic acid revealed specific modulation of LPS-induced-glycerolipids and LysoPC(18:0) with a significant reduction of microglial inflammation response. Our study introduces MALDI MS as a complementary technology for fast and label-free investigation of stimulus-dependent changes in lipid patterns and their modulation by pharmaceutical agents.
Insights
Matrix-assisted laser desorption/ionization mass spectrometry identified 21 lipid markers associated with microglial inflammation. This technique also revealed how suberoylanilide hydroxamic acid reduces neuroinflammation by modulating lipid profiles in microglia.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Pathological microglia activation drives neuroinflammation in neurodegenerative diseases, making it a therapeutic target.
- Altered lipid metabolism is increasingly recognized as a key factor in microglia activation and function.
- Understanding lipid dynamics in activated microglia is crucial for developing effective therapies.
Purpose of the Study:
- To investigate inflammation-associated lipid patterns in microglia using matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS).
- To identify potential lipid markers of microglial activation and inflammation.
- To explore the modulatory effects of pharmaceutical agents on microglial lipid profiles and inflammatory responses.
Main Methods:
- Developed and applied an extensive MALDI MS whole-cell fingerprinting workflow for SIM-A9 microglial cells.
- Utilized a synergistic platform of three MALDI MS technologies for comprehensive lipid profiling.
- Investigated lipid profile changes in response to lipopolysaccharide (LPS) stimulation and suberoylanilide hydroxamic acid treatment.
Main Results:
- Identified 21 potential inflammation-associated lipid markers, including phosphatidylcholines, lysophosphatidylcholines (LysoPC), sphingolipids, diacylglycerols, and triacylglycerols.
- Observed substantial differences in lipid profiles between LPS-stimulated and unstimulated microglia.
- Demonstrated that suberoylanilide hydroxamic acid specifically modulates LPS-induced glycerolipids and LysoPC(18:0), significantly reducing microglial inflammation.
Conclusions:
- MALDI MS is a valuable, label-free technology for rapid investigation of stimulus-dependent lipid changes in microglia.
- This approach facilitates the identification of novel lipid biomarkers for neuroinflammation.
- MALDI MS-based lipid fingerprinting can assess the efficacy of pharmaceutical agents in modulating microglial inflammatory responses.
